Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus

scientific article published on 01 January 2000

Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S004320050009
P698PubMed publication ID10641751

P2093author name stringJ Zhou
F Liu
J Fan
Z Y Tang
X M Li
Y K Liu
Z Q Wu
H C Sun
S L Ye
P433issue1
P921main subjectcell growthQ189159
hepatocellular carcinomaQ1148337
P304page(s)57-61
P577publication date2000-01-01
P1433published inJournal of Cancer Research and Clinical OncologyQ2081599
P1476titleExpression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus
P478volume126

Reverse relations

cites work (P2860)
Q35611503A decade's studies on metastasis of hepatocellular carcinoma
Q35701281Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives
Q41947562Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization
Q44269246Clinical characteristics and survival of European patients with resectable large hepatocellular carcinomas
Q35165648Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches
Q34382605Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma
Q35010945Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma
Q34452728Experimental study on enhancement of the metastatic potential of portal vein tumor thrombus-originated hepatocellular carcinoma cells using portal vein serum
Q36190339Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissue
Q44606862Expression of angiogenic factors in hepatocellular carcinoma after transcatheter arterial chemoembolization
Q35698574HCC and angiogenesis: possible targets and future directions
Q33695543Hedgehog inhibition reduces angiogenesis by downregulation of tumoral VEGF-A expression in hepatocellular carcinoma
Q35642468Hepatic stellate cells: central modulators of hepatic carcinogenesis
Q33410073Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase
Q34512068Hepatocellular carcinoma--cause, treatment and metastasis
Q45924805High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.
Q44193693High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice
Q33416414Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters
Q34457421Inhibition of vascular endothelial growth factor in the treatment of solid tumors
Q40468150Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.
Q44835572Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice
Q36474130Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection?
Q36917485Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.
Q92527657Macrophage-specific hypoxia-inducible factor-1α deletion suppresses the development of liver tumors in high-fat diet-fed obese and diabetic mice
Q48355658Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice
Q33412956Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
Q36474101Prognostic significance of preoperative circulating vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma: a prospective study
Q80059478Relationship between the changes of VEGF level and dendritic cells in peripheral blood of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
Q45871475Risk factors of poor prognosis and portal vein tumor thrombosis after curative resection of solitary hepatocellular carcinoma
Q60915777Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
Q34668320The prognostic molecular markers in hepatocellular carcinoma
Q37773788The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Q33405280Thrombocytosis and hepatocellular carcinoma

Search more.